Invention Grant
- Patent Title: Anti-EGFR combinations for treating tumors
-
Application No.: US17478153Application Date: 2021-09-17
-
Publication No.: US11702476B2Publication Date: 2023-07-18
- Inventor: Lixin Li
- Applicant: Birdie Biopharmaceuticals, Inc.
- Applicant Address: KY Grand Cayman
- Assignee: BIRDIE BIOPHARMACEUTICALS, INC.
- Current Assignee: BIRDIE BIOPHARMACEUTICALS, INC.
- Current Assignee Address: KY Grand Cayman
- Priority: CN 1610009256.8 2016.01.07
- The original application number of the division: US16068338
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K31/437 ; A61K31/4985 ; A61K31/519 ; A61K31/4745 ; A61P35/00 ; A61K31/429 ; A61K31/522 ; A61K45/06 ; A61K39/00 ; A61K38/16
Abstract:
The present invention relates to therapeutic combinations and methods for treating cancers using combination therapy.
Public/Granted literature
- US20220089749A1 ANTI-EGFR COMBINATIONS FOR TREATING TUMORS Public/Granted day:2022-03-24
Information query
